1. Cell-SELEX technology for aptamer selection<br>2. Biological characteristics of aptamers<br>3. Mechanisms of multi-drug resistance of cancer<br>4. Relevance of aptamers as targeting ligands for anticancer therapies<br>5. Aptamers as smart ligands for nano-carriers cancer targeting<br>6. Aptamer-functionalized liposomes for targeted cancer therapy<br>7. Aptamer-functionalized micelles for targeted cancer therapy<br>8. Aptamer-functionalized nanoparticles for targeted cancer therapy<br>9. Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy<br>10. Aptamer-functionalized silica nanoparticles for targeted cancer therapy<br>11. Aptamer-functionalized gold nanoparticles for targeted cancer therapy<br>12. Aptamer-functionalized dendrimers for targeted cancer therapy<br>13. Aptamer-functionalized carbon nanotubes for targeted cancer therapy<br>14. Aptamer-functionalized quantum dots for targeted cancer therapy<br>15. Cancer immunotherapy via nucleic acid aptamers<br>16. Aptamer-based imaging and diagnostics for cancer cells<br>17. Microdevice-based aptamer sensors<br>18. Aptamer-based microfluidics for circulating tumor cells<br>19. Aptamer-based theranostic approaches for treatment of cancer<br>20. Challenges of aptamers as targeting ligands for anticancer therapies<br>21. Clinical use and future perspective of aptamers
Bibliography
Includes bibliographical references and index.
Note
Description based on online resource; title from digital title page (viewed on June 12, 2023).
